In the present study, there was a significant reduction in IL-6 in the posttreatment period and in TNF-α and other cytokines, such as INF- γ, IL-1Ra, IL17, IL-13, and IL-8, after the use of EPP-AF. The gene discussed is IL17A; the disease is atrial fibrillation.